Back to Ameriprise Financial Inc. Ameriprise Financial Inc.

FATEFATE

Showing 6 of 27 quarters

Position history for Ameriprise Financial Inc.Ameriprise Financial Inc.'s holdings in Fate Therapeutics, Inc.

No. Ameriprise Financial exited its FATE (Fate Therapeutics) position in Q4 2025. Its Q3 2025 13F listed 261,671 shares worth $329,705. Ameriprise Financial first reported FATE in Q2 2019 and held it in 26 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$874,097

Total Shares Change

-249,742

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$0.98
0
2025-Q3
Decreased
261,671
-23.0%
$329,7050.0%$1.26
0
2025-Q2
Decreased
339,714
-17.4%
$380,4790.0%$1.12
0
2025-Q1
Increased
411,332
+132.2%
$324,9940.0%$0.79
38
2024-Q4
Decreased
177,161
-29.1%
$292,3160.0%$1.65
0
2024-Q3
Increased
249,742
+3.0%
$874,0970.0%$3.50
26

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used